Balkan Pharmaceuticals
Esculap
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 60 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: BALKAN PHARMACEUTICALS
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 60 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: BALKAN PHARMACEUTICALS
Out of stock
Trusted Balkan Pharmaceuticals Esculap Source
No reviews found
Please log in to write Esculap review.
Related Offers
Lab Tested
NEW
British Dragon Pharmaceuticals
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 TABLETS × 20 MG
ACTIVE HALF-LIFE: 36 HOURS
DOSAGE: 10–20 MG AS NEEDED
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: BRITISH DRAGON
LABORATORY TESTED: VIEW LAB RESULTS
Lab Tested
Domestic & International
Buy 3 and get 1 for FREE
Dragon Pharma, Europe
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
$61.00
Lab Tested
Stealth Labs
CLASSIFICATION: ERECTILE DYSFUNCTION (PDE5 INHIBITOR)
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 TABLETS (50 MG/TABLET)
ACTIVE HALF-LIFE: ~ 36 HOURS
DOSAGE: 10–50 MG PER USE OR 5–10 MG DAILY
ACNE: NONE
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): LOW RISK (MONITOR)
HEPATOTOXICITY: NONE
AROMATIZATION: NONE
MANUFACTURER: STEALTH LABS USA
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
Kalpa Pharmaceuticals LTD, India
CLASSIFICATION: PDE5 INHIBITOR (ERECTILE DYSFUNCTION AGENT)
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 TABLETS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: 10–20 MG AS NEEDED
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): MAY LOWER
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
Axiolabs
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: ORAL TABLETS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: AXIOLABS
Sunrise Remedies
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 5 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: SUNRISE REMEDIES
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 5 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: SUNRISE REMEDIES
Ajanta Pharma, India
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 10 SACHETS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: AJANTA PHARMA
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 10 SACHETS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: AJANTA PHARMA